Between huge ($800+ million) non-cash impairment charges weighing down net income on paper and the discontinuation of brands giving its sales hard comparisons to 2007, JNY's sales and profits seem lower than they truly are at first glance. Could be a time to look into a company whose bottom line may still be strong.